AMEX · Financial Statements

Nasus Pharma Ltd. (NSRX) Financial Statements

$3.51 AMEX: NSRX Market Cap $30.23M

Nasus Pharma Ltd. most recently reported annual revenue of $0, net profit of $-6.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2022202320242025
Revenue$0$0$0$0
Operating Profit$-2.0M$-1.0M$-1.0M$-5.0M
Net Profit$-2.0M$-1.0M$-2.0M$-6.0M
EPS$-0.19$-0.12$-0.17$-0.72
Op Margin————

Balance Sheet (USD)

Metric2022202320242025
Total Assets———$5.0M
Total Liabilities———$2.0M
Cash———$1.0M
Borrowings$0$0$0$0

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-1.0M$-1.0M$-1.0M$-5.0M
Investing Cash Flow$0$0$0$-3.0M
Financing Cash Flow$0$0$0$0
Net Cash Flow$0$0$0$1.0M
Free Cash Flow$-1.0M$-1.0M$-1.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA-3.10
FCF Yield-11.22%
Quick Ratio8.77
Interest Coverage0.00
Return 1Y-49.13%
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
NSRX Overview NSRX Dividend Run Stock Screener